Imaging and Staging of Esophageal Cancers

  • Tae Jung Kim


Esophageal cancer is one of the leading causes of cancer-related deaths worldwide, and the 5-year survival rate remains less than 20% in the United States. Surgical resection is currently the best treatment option for patients without distant metastases or locally advanced disease. Therefore, accurate staging of newly diagnosed can result in the most appropriate therapies being offered to patients who may potentially benefit. Currently, computed tomography (CT) and positron-emission tomography (PET)/CT are commonly used for the evaluation of distant metastases. Endoscopic ultrasound is the best modality for evaluation of tumor invasion depth and regional lymph node involvement. It is important to be familiar with staging system and particularly with multimodality approach for clinical staging because each modality has its own strengths and drawbacks for TNM staging. In this chapter, the 8th edition of TNM staging system for esophageal cancer and the diagnostic findings of esophageal cancer at CT, PET/CT, and endoscopic ultrasound are discussed in detail.


Esophagus Esophageal cancer Staging Imaging modality Computed tomography Positron emission tomography (PET)/CT Endoscopic ultrasound 



American Joint Committee on Cancer


Computed tomography


Endoscopic ultrasound


Multiplanar reformation


Positron emission tomography


Positron emission tomography/CT


Union for International Cancer Control


World Esophageal Cancer Consortium


  1. 1.
    Rice TW, Kelsen D, Blackstone EH, et al. Esophagus and esophagogastric junction. In: Amin MB, Edge S, Greene F, et al, eds. AJCC Cancer Staging Manual 8th ed New York: Springer;2017:185-202.Google Scholar
  2. 2.
    Kobori O, Kirihara Y, Kosaka N, Hara T. Positron emission tomography of esophageal carcinoma using 11 C-choline and 18 F-fluorodeoxyglucose. Cancer. 1999;86(9):1638–48.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Desai RK, Tagliabue JR, Wegryn SA, Einstein DM. CT evaluation of wall thickening in the alimentary tract. Radiographics. 1991;11(5):771–83.CrossRefPubMedGoogle Scholar
  4. 4.
    Noh HM, Fishman EK, Forastiere AA, Bliss DF, Calhoun PS. CT of the esophagus: spectrum of disease with emphasis on esophageal carcinoma. Radiographics. 1995;15(5):1113–34.CrossRefPubMedGoogle Scholar
  5. 5.
    Ravenel JG, Erasmus JJ. Azygoesophageal recess. J Thorac Imaging. 2002;17(3):219–26.CrossRefPubMedGoogle Scholar
  6. 6.
    Kim SH, Kim YJ, Lee JM, et al. Esophageal varices in patients with cirrhosis: multidetector CT esophagography—comparison with endoscopy. Radiology. 2007;242(3):759–68.CrossRefPubMedGoogle Scholar
  7. 7.
    Umeoka S, Koyama T, Togashi K, et al. Esophageal cancer: evaluation with triple-phase dynamic CT—initial experience. Radiology. 2006;239(3):777–83.CrossRefPubMedGoogle Scholar
  8. 8.
    Kim TJ, Kim HY, Lee KW, Kim MS. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics. 2009;29(2):403–21.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Swisher SG, Maish M, Erasmus JJ, et al. Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer. Ann Thorac Surg. 2004;78(4):1152–60.CrossRefPubMedGoogle Scholar
  10. 10.
    Westerterp M, van Westreenen HL, Reitsma JB, et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy—systematic review. Radiology. 2005;236(3):841–51.CrossRefPubMedGoogle Scholar
  11. 11.
    Kelly S, Harris KM, Berry E, et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut. 2001;49(4):534–9.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Rosch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am. 1995;5(3):537–47.CrossRefPubMedGoogle Scholar
  13. 13.
    Souquet JC, Napoleon B, Pujol B, et al. Endoscopic ultrasonography in the preoperative staging of esophageal cancer. Endoscopy. 1994;26(9):764–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Zuccaro G, Rice TW, Goldblum J, et al. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol. 1999;94(4):906–12.CrossRefPubMedGoogle Scholar
  15. 15.
    Lightdale CJ, Kulkarni KG. Role of Endoscopic Ultrasonography in the Staging and Follow-Up of Esophageal Cancer. J Clin Oncol. 2005;23(20):4483–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Brown LM, Devesa SS, Chow W-H. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008;100(16):1184–7.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Hong SJ, Kim TJ, Nam KB, et al. New TNM staging system for esophageal cancer: what chest radiologists need to know. Radiographics. 2014;34(6):1722–40.CrossRefPubMedGoogle Scholar
  18. 18.
    Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology. 2000;118(4):670–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Wakelin SJ, Deans C, Crofts TJ, Allan PL, Plevris JN, Paterson-Brown S. A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur J Radiol. 2002;41(2):161–7.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Wallace MB, Nietert PJ, Earle C, et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg. 2002;74(4):1026–32.CrossRefPubMedGoogle Scholar
  21. 21.
    Rice TW. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am. 2000;10(3):471–85.PubMedGoogle Scholar
  22. 22.
    Daffner RH, Halber MD, Postlethwait RW, Korobkin M, Thompson WM. CT of the esophagus. II. Carcinoma. AJR Am J Roentgenol. 1979;133(6):1051–5.CrossRefPubMedGoogle Scholar
  23. 23.
    Picus D, Balfe DM, Koehler RE, Roper CL, Owen JW. Computed tomography in the staging of esophageal carcinoma. Radiology. 1983;146(2):433–8.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Takashima S, Takeuchi N, Shiozaki H, et al. Carcinoma of the esophagus: CT vs MR imaging in determining resectability. AJR Am J Roentgenol. 1991;156(2):297–302.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol. 1997;168(2):417–24.CrossRefPubMedGoogle Scholar
  26. 26.
    Mariette C, Castel B, Balon J, Van Seuningen I, Triboulet J. Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol. 2003;29(7):588–93.CrossRefPubMedGoogle Scholar
  27. 27.
    Casson AG, Darnton SJ, Subramanian S, Hiller L. What is the optimal distal resection margin for esophageal carcinoma? Ann Thorac Surg. 2000;69(1):205–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Reed CE, Eloubeidi MA. New techniques for staging esophageal cancer. Surg Clin N Am. 2002;82(4):697–710.CrossRefPubMedGoogle Scholar
  29. 29.
    Hasegawa N, Niwa Y, Arisawa T, Hase S, Goto H, Hayakawa T. Preoperative staging of superficial esophageal carcinoma: comparison of an ultrasound probe and standard endoscopic ultrasonography. Gastrointest Endosc. 1996;44(4):388–93.CrossRefPubMedGoogle Scholar
  30. 30.
    Murata Y, Suzuki S, Ohta M, et al. Small ultrasonic probes for determination of the depth of superficial esophageal cancer. Gastrointest Endosc. 1996;44(1):23–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Hordijk ML, Kok TC, Wilson JH, Mulder AH. Assessment of response of esophageal carcinoma to induction chemotherapy. Endoscopy. 1993;25(9):592–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Tio TL, Cohen P, Coene PP, Udding J, den Hartog Jager FC, Tytgat GN. Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new (1987) TNM system. Gastroenterology 1989;96(6):1478-1486.Google Scholar
  33. 33.
    Rice T, Rusch V, Apperson-Hansen C, et al. Worldwide esophageal cancer collaboration. Dis Esophagus. 2009;22(1):1–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Dorfman RE, Alpern MB, Gross BH, Sandler MA. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology. 1991;180(2):319–22.CrossRefPubMedGoogle Scholar
  35. 35.
    Fultz PJ, Feins RH, Strang JG, et al. Detection and Diagnosis of Nonpalpable Supraclavicular Lymph Nodes in Lung Cancer at CT and US. Radiology. 2001;222:245–51.CrossRefGoogle Scholar
  36. 36.
    Block MI, Patterson GA, Sundaresan RS, et al. Improvement in Staging of Esophageal Cancer With the Addition of Positron Emission Tomography. Ann Thorac Surg. 1997;64(3):770–7.CrossRefPubMedGoogle Scholar
  37. 37.
    Kato H, Kuwano H, Nakajima M, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer. 2002;94(4):921–8.CrossRefPubMedGoogle Scholar
  38. 38.
    Flamen P, Lerut A, Van Cutsem E, et al. Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma. J Clin Oncol. 2000;18(18):3202–10.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Parmar KS, Zwischenberger JB, Reeves AL, Waxman I. Clinical impact of endoscopic ultrasound-guided fine needle aspiration of celiac axis lymph nodes (M1a disease) in esophageal cancer. Ann Thorac Surg. 2002;73(3):916–20.CrossRefPubMedGoogle Scholar
  40. 40.
    Van Vliet E, Heijenbrok-Kal M, Hunink M, Kuipers E, Siersema P. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer. 2008;98(3):547–57.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Quint LE, Hepburn LM, Francis IR, Whyte RI, Orringer MB. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer. 1995;76(7):1120–5.CrossRefPubMedGoogle Scholar
  42. 42.
    Margolis ML, Howlett P, Bubanj R. Pulmonary nodules in patients with esophageal carcinoma. J Clin Gastroenterol. 1998;26(4):245–8.CrossRefPubMedGoogle Scholar
  43. 43.
    Van Westreenen H, Westerterp M, Bossuyt P, et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol. 2004;22(18):3805–12.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Downey RJ, Akhurst T, Ilson D, et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol. 2003;21(3):428.CrossRefPubMedGoogle Scholar
  45. 45.
    Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14(4):459–65.CrossRefPubMedGoogle Scholar
  46. 46.
    Pichler BJ, Kolb A, Nägele T, Schlemmer H-P. PET/MRI: paving the way for the next generation of clinical multimodality imaging applications. J Nucl Med. 2010;51(3):333–6.CrossRefPubMedGoogle Scholar
  47. 47.
    Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234(3):360.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Rice TW, Rusch VW, Ishwaran H, Blackstone EH. Cancer of the esophagus and esophagogastric junction. Cancer. 2010;116(16):3763–73.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Tae Jung Kim
    • 1
  1. 1.Department of RadiologySamsung Medical CenterSeoulRepublic of Korea

Personalised recommendations